The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab.
作者信息
Wang Lan, Bargout Miriam, Hon Jane Date, Yaghmour Bassam, Mohrbacher Ann, Yaghmour George
机构信息
Division of Hematology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA.
Division of Pathology, University of Southern California, Los Angeles, CA 90033, USA.
出版信息
World J Oncol. 2020 Feb;11(1):41-43. doi: 10.14740/wjon1255. Epub 2020 Feb 2.
Abstract
摘要
相似文献
1
The Emergence of Epstein-Barr Virus-Related Diffuse Large B-Cell Lymphoma With Mogamulizumab.莫加莫珠单抗治疗相关的爱泼斯坦-巴尔病毒相关性弥漫性大B细胞淋巴瘤的出现
World J Oncol. 2020 Feb;11(1):41-43. doi: 10.14740/wjon1255. Epub 2020 Feb 2.
2
Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment.在接受莫加莫单抗治疗后诊断为外周T细胞淋巴瘤（未另行分类）的患者中发生的与爱泼斯坦-巴尔病毒相关的原发性中枢神经系统弥漫性大B细胞淋巴瘤
Intern Med. 2017 Oct 15;56(20):2759-2763. doi: 10.2169/internalmedicine.8781-16. Epub 2017 Sep 15.
3
Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.台湾地区爱泼斯坦-巴尔病毒阳性弥漫性大B细胞淋巴瘤患者的临床特征与治疗结果
Jpn J Clin Oncol. 2014 Dec;44(12):1164-71. doi: 10.1093/jjco/hyu155. Epub 2014 Oct 15.
4
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression.北美的弥漫性大 B 细胞淋巴瘤患者的预后与肿瘤的 Epstein-Barr 病毒阳性或免疫抑制无关。
Haematologica. 2018 Feb;103(2):297-303. doi: 10.3324/haematol.2017.176511. Epub 2017 Nov 23.
5
Epstein-Barr virus-positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype.美国一家三级医疗中心的老年爱泼斯坦-巴尔病毒阳性B细胞淋巴瘤：一种具有非生发中心B细胞表型的罕见侵袭性淋巴瘤。
Hum Pathol. 2009 May;40(5):653-61. doi: 10.1016/j.humpath.2008.10.007. Epub 2009 Jan 13.
6
Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.儿童EB病毒阳性弥漫性大B细胞淋巴瘤：一种类似于老年EB病毒阳性弥漫性大B细胞淋巴瘤的疾病。
Hum Pathol. 2015 May;46(5):716-24. doi: 10.1016/j.humpath.2015.01.011. Epub 2015 Feb 3.
7
8
Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.口腔非霍奇金淋巴瘤中EB病毒的检测：一项免疫细胞化学和原位杂交研究
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):184-93. doi: 10.1067/moe.2001.116155.
9
Primary central nervous system diffuse large B-cell lymphoma in the immunocompetent: Immunophenotypic subtypes and Epstein-Barr virus association.免疫功能正常者的原发性中枢神经系统弥漫性大B细胞淋巴瘤：免疫表型亚型与爱泼斯坦-巴尔病毒的关联
J Neurosci Rural Pract. 2015 Jan;6(1):8-14. doi: 10.4103/0976-3147.143171.
10
Lymphomas of the oral soft tissues are not preferentially associated with latent or replicative Epstein-Barr virus.口腔软组织淋巴瘤与潜伏性或复制性爱泼斯坦-巴尔病毒并无优先关联。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995 Oct;80(4):425-31. doi: 10.1016/s1079-2104(05)80336-1.
引用本文的文献
1
Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review.莫格利珠单抗的临床和真实世界疗效：一项叙述性综述。
Int J Mol Sci. 2024 Feb 12;25(4):2203. doi: 10.3390/ijms25042203.
本文引用的文献
1
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome.FDA 批准概要：莫格利珠单抗-kpkc 治疗蕈样真菌病和塞扎里综合征。
Clin Cancer Res. 2019 Dec 15;25(24):7275-7280. doi: 10.1158/1078-0432.CCR-19-2030. Epub 2019 Jul 31.
2
Angioimmunoblastic T-Cell Lymphoma.血管免疫母细胞性T细胞淋巴瘤
Cancer Treat Res. 2019;176:99-126. doi: 10.1007/978-3-319-99716-2_5.
3
Epstein-Barr virus-related diffuse large B-cell lymphoma in mogamulizumab-treated adult T-cell leukemia with incomplete T-cell reconstitution.在接受莫加莫珠单抗治疗且T细胞重建不完全的成人T细胞白血病中发生的与爱泼斯坦-巴尔病毒相关的弥漫性大B细胞淋巴瘤。
Int J Hematol. 2019 Feb;109(2):221-227. doi: 10.1007/s12185-018-2552-x. Epub 2018 Oct 27.
4
Development of Epstein-Barr Virus-related Primary Diffuse Large B-cell Lymphoma of the Central Nervous System in a Patient with Peripheral T-cell Lymphoma, Not Otherwise Specified after Mogamulizumab Treatment.在接受莫加莫单抗治疗后诊断为外周T细胞淋巴瘤（未另行分类）的患者中发生的与爱泼斯坦-巴尔病毒相关的原发性中枢神经系统弥漫性大B细胞淋巴瘤
Intern Med. 2017 Oct 15;56(20):2759-2763. doi: 10.2169/internalmedicine.8781-16. Epub 2017 Sep 15.
5
Mogamulizumab for relapsed adult T-cell leukemia-lymphoma: Updated follow-up analysis of phase I and II studies.莫格利珠单抗治疗复发的成人T细胞白血病-淋巴瘤：I期和II期研究的更新随访分析
Cancer Sci. 2017 Oct;108(10):2022-2029. doi: 10.1111/cas.13343. Epub 2017 Aug 28.
6
Cytomegalovirus Pneumonia after Anti-CC-chemokine Receptor 4 Monoclonal Antibody (Mogamulizumab) Therapy in an Angioimmunoblastic T-cell Lymphoma Patient.抗CC趋化因子受体4单克隆抗体（莫加莫拉单抗）治疗血管免疫母细胞性T细胞淋巴瘤患者后发生的巨细胞病毒肺炎
Intern Med. 2016;55(6):673-5. doi: 10.2169/internalmedicine.55.5644. Epub 2016 Mar 15.
7
Gain-of-function CCR4 mutations in adult T cell leukemia/lymphoma.功能获得性 CCR4 突变在成人 T 细胞白血病/淋巴瘤中的作用。
J Exp Med. 2014 Dec 15;211(13):2497-505. doi: 10.1084/jem.20140987. Epub 2014 Dec 8.
8
Reduction of regulatory T cells by Mogamulizumab, a defucosylated anti-CC chemokine receptor 4 antibody, in patients with aggressive/refractory mycosis fungoides and Sézary syndrome.莫格利珠单抗（一种去岩藻糖基化的抗 CC 趋化因子受体 4 抗体）降低侵袭性/难治性蕈样肉芽肿和塞扎里综合征患者的调节性 T 细胞。
Clin Cancer Res. 2015 Jan 15;21(2):274-85. doi: 10.1158/1078-0432.CCR-14-0830. Epub 2014 Nov 5.
9
Expression of CCR4 in adult T-cell leukemia.CCR4在成人T细胞白血病中的表达。
Leuk Lymphoma. 2005 Feb;46(2):185-90. doi: 10.1080/10428190400007607.
Zotero 插件